Medical professionals are identifying a new aesthetic side effect known as "Ozempic arms," which involves sagging skin on the upper limbs following significant weight reduction.. This phenomenon follows earlier discussions regarding "Ozempic face," as users of GLP-1 receptor agonists experience rapid changes in body composition.

The "batwing effect" of rapid fat depletion

The emergence of "Ozempic arms" is part of a broader trend of skin laxity following extreme weight loss.. As the report notes, this follows previous observations of "Ozempic face," "Ozempic feet," and "Ozempic butt," all of which describe the irreversible loss of skin elasticity when body mass drops too quickly. This issue is not merely a cosmetic quirk but a physiological consequence of how the body sheds fat across various regions.

As these medications effectively suppress appetite, the body sheds fat from areas that rely on subcutaneous layers for firmness.. This systemic process means that even if a user targets specific areas for weight loss, the skin across the entire body—including the arms—may lose the structural support necessary to remain taut.

Dr. Ross Perry on the loss of skin tension

According to Dr. Ross Perry, the Medical Director of Cosmedics skin clinics, the issue arises because the skin relies on underlying subcutaneous fat for structural support. When medications like Ozempic and Mounjaro cause fat stores to vanish, the skin often fails to contract at the same rate. Dr. Perry describes this as a "batwing effect," where the skin on the triceps hangs loosely, creating a crepey texture and making the limbs appear prematurely aged.

This lack of tension is exacerbated by the natural biological decline of collagen and elastin. Because these proteins decrease as individuals age,the skin often cannot keep pace with the disappearing fat. This makes the phenomenon particularly prevalent in patients over the age of 35, with factors like menopause and sun exposure further complicating the skin's ability to bounce back.

The unverified link between celebrity transformations and GLP-1 use

Public interest in these side effects has been driven by observations of famous celebrities, though much of the connection to weight-loss drugs remains unconfirmed. For instance , the report mentions that observers have pointed to the upper arms of Demi Moore and Nicole Kidman as potential evidence of medication use.. Similarly, Kelly Osbourne has been a subject of these discussions despite her explicit denials of using such treatments. It remains unclear whether these visible changes are due to GLP-1 agonists or other factors like natural aging or surgical interventions.

The limits of mitigating a 20% body weight loss

While lifestyle changes are often recommended, the scale of weight loss seen with these drugs makes skin sagging difficult to avoid. As the report states, these medications can lead to an average weight loss ranginng from 15 to 20 percent of a person's total body weight. Aesthetic doctor Dr. Emma Goulding emphasizes that the drugs themselves do not chemically damage the skin; rather, the speed of the weight loss deprives the dermis of its foundation.

To combat this, medical professionals often suggest maintaining muscle mass through strength training and staying hydrated . However, for those with lower muscle mass or existing skin laxity, these measures may not be enough to prevent the "Ozempic arms" phennomenon. The pursuit of a thinner frame may, therefore, come with lasting changes to the body's dermal structure.